𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Positron emission tomography in Shy-Drager syndrome

✍ Scribed by Mohit H. Bhatt; Barry J. Snow; W. R. Wayne Martin; Sandra Cooper RN; Dr Donald B. Calne

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
351 KB
Volume
28
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Positron emission tomography in manganes
Positron emission tomography in manganese intoxication
✍ E. Ch Wolters; C.-C. Huang; C. Clark; R. F. Peppard; J. Okada; N.-S. Chu; M. J. πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 487 KB πŸ‘ 2 views
Positron emission tomography in patients
Positron emission tomography in patients with fibromyalgia syndrome and healthy controls
✍ Yunus, Muhammad B. ;Young, Carter S. ;Saeed, S. Atezaz ;Mountz, James M. ;Aldag, πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 1 views

## Abstract ## Objective Abnormal brain findings have previously been described in fibromyalgia syndrome (FMS) by single‐photon–emission computed tomography. Our goal was to investigate change in regional cerebral glucose metabolism in people with FMS by positron emission tomography (PET) using ^1

Pharmacokinetics of radiotracers in huma
Pharmacokinetics of radiotracers in human plasma during positron emission tomography
✍ Paul Cumming; Fuji Yokoi; Anjing Chen; Paul Deep; Alain Dagher; David Reutens; F πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

Many radiopharmaceuticals for positron emission tomography (PET) are substantially metabolized in peripheral organs. Pharmacological treatments intended to alter cerebral metabolism might also alter radiotracer metabolism, consequently altering the cerebral uptake. First-order rate constants for the